Navigation Links
Cliantha Research Partners with Acceliant for its Clinical Trials

BANGALORE, India, February 27, 2013 /PRNewswire/ --

Acceliant, a global technology provider of innovative clinical trial data management solutions, today announced that Cliantha Research, a leading global Contract Research Organization, has chosen Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant's integrated e-PRO/EDC system offers a superior solution by allowing all the study data to be readily available, eliminating the integration costs.

Speaking of the partnership, Hitesh Chauhan , Associate Director of Biometrics at Cliantha Research, said, "We evaluated and selected Acceliant eClinical Suite because we found it to be very user-friendly and superior to several other products. Besides being a platform with best-in-class features, Acceliant's eClinical Suite is architected process and system wise to drive efficiency, lower costs and accelerate clinical trial studies."

On the occasion, Ven Thangaraj, CTO of Acceliant, said, "The Life Sciences industry is going through dramatic changes and pressures to innovate while keeping costs under control. Acceliant is one of the few integrated EDC-ePRO platforms with innovative workflows and built-in mobility which allows data management from anywhere, anytime."

Santhosh S. Nagaraj, Acceliant's India Sales Head , commented, "We are proud to be associated with Cliantha Research and helping them in their clinical studies. Our differentiation as a robust platform that accelerates trials through efficient data management is what helped us win. We look forward to a successful long-term relationship and continued growth in India."

Acceliant is also pleased to announce its participation at the BioPharma Asia Convention 2013, one of the largest annual biopharmaceutical industry gatherings in Asia. The convention will be held in Singapore from March 18-21. Acceliant will be in Booth #D24 and will showcase its comprehensive eClinical Suite, interact with global experts, and explore more partnership opportunities.

About Cliantha Research

Cliantha Research, a leading life sciences company, is a global full service Contract Research Organization with integrated offerings in Clinical, Bioanalytical, Dermatology, Biometrics, Pathology and Formulation services. The company has its presence in the US, Canada, Mexico, and India. Cliantha Research's facilities have been audited by the AGES (Austrian regulatory agency), ANSM (French regulatory agency), AEMPS (Spanish regulatory agency), USFDA, MCC (South African regulatory agency), WHO and International companies. The Central Reference lab at Cliantha is accredited by College of American Pathologists (CAP). Cliantha Research has successfully conducted and executed over 5000 studies and has analyzed over 1.5 million samples.

About Acceliant

Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant has helped facilitate clinical data management in hundreds of trials worldwide encompassing dozens of therapeutic areas for global giants as well as emerging healthcare innovators.

Prashant Bhavaraju
Chief Marketing Officer, Acceliant

SOURCE Acceliant
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research
Post Your Comments:
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
Breaking Medicine News(10 mins):